These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19673118)

  • 1. [Possibilities of combined and isolated application of carbapenems in patients with secondary widespread peritonitis].
    Pidhirnyĭ Ia; Baryliak R; Makovets'kyĭ I; Shershen' H; Pidhirna M
    Klin Khir; 2009 Mar; (3):28-33. PubMed ID: 19673118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary and tertiary peritonitis: the role of antibacterial therapy in the complex treatment].
    Shliapnikov SA; Efimova IS
    Antibiot Khimioter; 2001; 46(12):35-41. PubMed ID: 12108092
    [No Abstract]   [Full Text] [Related]  

  • 3. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Piano S; Fasolato S; Salinas F; Romano A; Tonon M; Morando F; Cavallin M; Gola E; Sticca A; Loregian A; Palù G; Zanus G; Senzolo M; Burra P; Cillo U; Angeli P
    Hepatology; 2016 Apr; 63(4):1299-309. PubMed ID: 26084406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary peritonitis caused by Streptococcus pneumoniae].
    Garnache F; Simon M; Goffinet P
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(6):617-22. PubMed ID: 9453979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical-economic analysis of antibacterial therapy of acute peritonitis].
    Bezdetko NV; Bereznitskiĭ IaS
    Klin Khir; 2011 Aug; (8):39-45. PubMed ID: 22013688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and impact of preparation ronem on endogenous intoxication severity in the patients with deep burns].
    Kozinets GP; Osadchaia OI; Boiarskaia AM; Tsygankov VP; Isaenko NP; Solodkiĭ IuA
    Klin Khir; 2008 Oct; (10):55-60. PubMed ID: 19408395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of carbapenems in combined therapy of patients with common forms of peritonitis].
    Khachatrian NN; Dibirov MD; Poliakov IA; Khmelevskiĭ SV; Karsot'ian GS
    Khirurgiia (Mosk); 2007; (7):51-6. PubMed ID: 17855860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience of application of meronem in the treatment of severe purulent sepsis in children].
    Sleptsov VP; Kirsanov AI; Usachenko VP; Ivanova OV; Stepkina OI; Belkina IuE; Bondarenko IV; Panasenko VV
    Klin Khir; 2002 Jan; (1):40-1. PubMed ID: 11944296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
    Kotapati S; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):297-304. PubMed ID: 16201939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tertiary peritonitis].
    Castañón-González JA; Canto-Castro JL; León-Guitiérrez MA
    Cir Cir; 2006; 74(6):407-8. PubMed ID: 17244495
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
    Castagnola E; Bandettini R; Ginocchio F; Perotti M; Masa DL; Ciucci A; Loy A; Caviglia I; Haupt R; Guida E; Pini Prato A; Mattioli G; Buffa P
    J Chemother; 2013 Aug; 25(4):213-6. PubMed ID: 23906074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
    Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous bacteremia and spontaneous bacterial peritonitis in cirrhosis: two infections but similar outcomes?
    Maiwall R
    Hepatol Int; 2018 Mar; 12(2):87-89. PubMed ID: 29589197
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibacterial therapy of severe intra-abdominal infections].
    Boĭko VV; Ivanova IuV
    Klin Khir; 2011 Sep; (9):43-6. PubMed ID: 22168024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of clinical efficacy of serotonin adipate in treatment and prevention of enteral insufficiency syndrome at generalized peritonitis].
    Belik BM
    Khirurgiia (Mosk); 2016; (9):76-82. PubMed ID: 27723700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carbapenems (thienam and Meronem). Their clinical and economic efficacy].
    Mariutin PV; Mikhaĭlovich DV; Uchvatkin VG; Kravets SG
    Anesteziol Reanimatol; 1998; (4):20-2. PubMed ID: 9770812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
    Novovic S; Semb S; Olsen H; Moser C; Knudsen JD; Homann C
    Scand J Gastroenterol; 2012 Feb; 47(2):212-6. PubMed ID: 22191479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspergillus peritonitis--a case report].
    Patyi M; Svébis M
    Magy Seb; 2010 Dec; 63(6):384-6. PubMed ID: 21147673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined forecasting system of peritonitis outcome].
    Lebedev NV; Klimov AE; Agrba SB; Gaidukevich EK
    Khirurgiia (Mosk); 2017; (9):33-37. PubMed ID: 28914830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoclonus associated with intraperitoneal imipenem.
    Lau KK; Kink RJ; Jones DP
    Pediatr Nephrol; 2004 Jun; 19(6):700-1. PubMed ID: 15052466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.